首页> 外文学位 >The application of liposomes for solubilisation of hydrophobic drugs.
【24h】

The application of liposomes for solubilisation of hydrophobic drugs.

机译:脂质体在疏水药物增溶中的应用。

获取原文
获取原文并翻译 | 示例

摘要

The application of liposomes for the solubilisation of lipophilic hydrophobes for intravenous administration has been investigated. The lipid composition of four commercially available phospholipids extracted from soya bean and egg sources were studied. The particle size of liposome dispersions generated from pro-liposomes made from these four phospholipids was determined using a variety of sizing techniques. Various factors potentially affecting the particle size such as the degree of agitation, lipid composition and hydration of the liposome were studied. The size distribution of the dispersions without drug were compared to a commercially available intravenous emulsion. The stability of three placebo anhydrous lipid formulations was examined under accelerated conditions. The harsh conditions induced extensive browning in the soya phospholipid and egg phospholipid samples. Oxidative changes were most pronounced in the soya phosphatidylcholine formulations. Long term stability studies at 40 °C, 20 °C and 4 °C were also carried out on a specific soya phospholipid blend proliposome formulation. In this particular study, the oxidative status of the lipid remained essentially unchanged throughout the test period. The model hydrophobe selected for these studies was the immunosupressant cyclosporin A (cyA). Association of cyA was found to be dependent upon a careful balance of the pro-liposome components. Furthermore, association was further improved by hydrating the pro-liposome with an appropriate amount of water. Freeze drying was investigated as a possible alternative presentation of cyA liposomes. Studies on drug-free dispersions revealed that successful freeze drying was reliant upon a variety of factors such as lipid composition, careful selection of stabilisers and freezing. The particle size of all liposome dispersions examined was larger than the original dispersion prior to lyophilisation. However, the association of cyA was unaffected by freeze drying. After rehydration, cyA remained associated with all the liposome dispersions tested- even those which had fused/aggregated to a large extent.
机译:已经研究了脂质体在增溶用于静脉内施用的亲脂性疏水物中的应用。研究了从大豆和鸡蛋中提取的四种市售磷脂的脂质组成。使用多种上浆技术确定由这四种磷脂制成的前脂质体产生的脂质体分散体的粒径。研究了可能影响粒径的各种因素,例如搅动程度,脂质组成和脂质体的水合作用。将没有药物的分散体的尺寸分布与可商购的静脉内乳液进行比较。在加速条件下检查了三种安慰剂无水脂质制剂的稳定性。苛刻的条件在大豆磷脂和鸡蛋磷脂样品中引起大量褐变。大豆磷脂酰胆碱配方中的氧化变化最为明显。还对特定的大豆磷脂混合脂质体前体制剂在40°C,20°C和4°C下进行了长期稳定性研究。在此特定研究中,脂质的氧化状态在整个测试期间基本保持不变。为这些研究选择的疏水模型是免疫抑制剂环孢菌素A(cyA)。发现cyA的缔合取决于脂质体原组分的仔细平衡。此外,通过用适当量的水将脂质体原水合来进一步改善缔合。研究了冷冻干燥作为cyA脂质体的一种可能替代形式。对无药物分散体的研究表明,成功的冷冻干燥取决于多种因素,例如脂质组成,稳定剂的精心选择和冷冻。检查的所有脂质体分散体的粒度均大于冻干前的原始分散体。然而,cyA的缔合不受冻干的影响。补液后,cyA仍与所有测试的脂质体分散体相关联,即使那些已在很大程度上融合/聚集的脂质体也是如此。

著录项

  • 作者

    Leigh, Mathew Louis Steven.;

  • 作者单位

    University of London, University College London (United Kingdom).;

  • 授予单位 University of London, University College London (United Kingdom).;
  • 学科 Pharmaceutical sciences.
  • 学位 Ph.D.
  • 年度 1997
  • 页码 285 p.
  • 总页数 285
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号